Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
#1 most reported symptom for this vaccine
Headache has been reported 1,716 times in association with Meningococcal B (Trumenba) vaccination in VAERS. This represents 15.2% of all 11,323 reports for this vaccine.
Among these reports, 6 mentioned death (0.35%) and 108 involved hospitalization (6.3%).
Headache is the #1 most frequently reported symptom for Meningococcal B (Trumenba) out of 869 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
Seeing 1,716 reports of Headache after Meningococcal B (Trumenba) vaccination may seem alarming, but context is critical.
The mortality rate among these reports is very low at 0.35%, suggesting most cases are non-fatal.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.